Upfront or Deferred Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Triplet and Quadruplet Induction and Minimal Residual Disease/Risk-Adapt... by Clifton C. Mo, Monique A. Hartley-Brown, Shonali Midha, Paul G. Richardson

Get full text

Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones by Maho Terashita, Umut Selamet, Shonali Midha, Omar Nadeem, Jacob Laubach, Helmut G. Rennke, Naoka Murakami

Get full text

Mezigdomide—A Novel Cereblon E3 Ligase Modulator under Investigation in Relapsed/Refractory Multiple Myeloma by Monique A. Hartley-Brown, Clifton C. Mo, Omar Nadeem, Shonali Midha, Jacob P. Laubach, Paul G. Richardson

Get full text

Selinexor: Targeting a novel pathway in multiple myeloma by Clifton C. Mo, Andrew J. Yee, Shonali Midha, Monique A. Hartley‐Brown, Omar Nadeem, Elizabeth K. O'Donnell, Giada Bianchi, Adam S. Sperling, Jacob P. Laubach, Paul G. Richardson

Get full text

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium by Aimaz Afrough, Hamza Hashmi, Doris K. Hansen, Surbhi Sidana, Chul Ahn, Lauren C. Peres, Danai Dima, Ciara L. Freeman, Omar Castaneda Puglianini, Mehmet H. Kocoglu, Shebli Atrash, Peter M. Voorhees, Leyla Shune, Joseph P. McGuirk, Gary Simmons, Douglas W. Sborov, James A. Davis, Gurbakhash Kaur, Aishwarya Sannareddy, Christopher J. Ferreri, Mahmoud R. Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B. Wagner, Frederick L. Locke, Krina K. Patel, Jack Khouri, Larry D. Anderson, Yi Lin

Get full text